Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gangliosides in neuroblastomas.

C L Schengrund1, S J Shochat

  • 1Department of Biological Chemistry, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA 17033.

Neurochemical Pathology
|June 1, 1988
PubMed
Summary

Low levels of specific gangliosides (GT1b and GD1b) in neuroblastoma tumors correlate with a poor prognosis. Thoracic neuroblastomas, with higher GT1b/GD1b levels, show better outcomes, suggesting gangliosides may indicate tumor differentiation and patient prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of a pediatric surgical oncology fellowship in a pediatric cancer institution.

Pediatric blood & cancer·2017
Same author

Guidewire Catheter Exchange in Pediatric Oncology: Indications, Postoperative Complications, and Outcomes.

Pediatric blood & cancer·2016
Same author

Ganglioside sialidase activity in bovine neuronal perikarya.

Neurochemical research·2013
Same author

Sialidase activity in mouse neuroblastoma cell lines.

Neurochemical research·2013
Same author

Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children.

Pediatric blood & cancer·2011
Same author

Is reexcision in pediatric nonrhabdomyosarcoma soft tissue sarcoma necessary after an initial unplanned resection?

Journal of pediatric surgery·2002

Area of Science:

  • Biochemistry
  • Oncology
  • Neuroscience

Background:

  • Neuroblastomas are pediatric tumors with varied prognoses.
  • Gangliosides are complex glycosphingolipids found in cell membranes, particularly in the nervous system.
  • Specific ganglioside profiles may correlate with tumor behavior and patient outcomes.

Purpose of the Study:

  • To investigate the relationship between ganglioside patterns and neuroblastoma prognosis.
  • To determine if ganglioside composition can serve as a diagnostic marker or prognostic indicator.
  • To explore the role of gangliosides in neuroblastoma cell differentiation.

Main Methods:

  • Analysis of ganglioside patterns in 53 neuroblastoma tumors from children.
  • Correlation of ganglioside levels (GT1b, GD1b, GD2, monosialogangliosides) with patient disease status (disease-free vs. disease-positive/dead).
  • Comparison of ganglioside composition in thoracic neuroblastomas versus other primary sites.
  • In vitro study of ganglioside effects on neuroblastoma cell neuritogenesis.

Main Results:

  • Lower levels of GT1b and GD1b were significantly associated with disease progression or death (p < 0.005).
  • Higher concentrations of GT1b and GD1b, and lower monosialogangliosides, were found in thoracic neuroblastomas, which have a better prognosis (p < 0.005 and p < 0.025, respectively).
  • GD2 was present in 45 tumors, suggesting its potential as a diagnostic marker.
  • The oligosaccharide from GM1 enhanced neuritogenesis in murine neuroblastoma cells, similar to GM1.

Conclusions:

  • Low levels of GT1b and GD1b gangliosides are linked to a poor prognosis in neuroblastoma.
  • Thoracic neuroblastomas may represent a more differentiated cell type, contributing to their better prognosis.
  • Ganglioside profiles, particularly GT1b and GD1b levels, show promise as prognostic indicators for neuroblastoma.
  • Gangliosides may play a role in neuronal differentiation, influencing neuroblastoma behavior.

Related Experiment Videos